Analysis of electromagnetic transponders tracking data to quantify intrafraction prostate motion during radiotherapy treatments

Carrara, M.; Giandini, T.; Bonfantini, F.; Avuzzi, B.; Villa, Sergio; Bedini, N.; Morlino, S.; Carabelli, Gabriele; Frasca, S.; Valdagni, Riccardo; Pignoli, E.

doi:10.1088/1742-6596/777/1/012036

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Intrafraction prostate motion is a predominant cause for treatment delivery inaccuracies as multiple studies have shown that the prostate tends to move in an unpredictable way in approximately 50% of all patients with observed motion amplitudes up to 2 cm for certain extreme cases . The dosimetric impact of this residual intrafraction motion is nonnegligible and should be mitigated by accurate monitoring of the prostate position during treatment delivery .…”

Section: Introductionmentioning

confidence: 99%

Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer

et al. 2018

View full text Add to dashboard Cite

This study is the first to show the compatibility of BioXmark liquid markers with multimodal image-guided radiotherapy for PCa. Compared to a solid gold marker, they had favorable results in both visibility and induced imaging artifacts. Liquid marker visibility in MRI imaging of the prostate does not solely depend on the low ρH value (not visible on T2-weighted image) but is also influenced by its relaxation times. Automated marker detection in x-ray images was feasible but better adapted marker detection algorithms are necessary for marker localization in the presence of bony edges. Hence, the liquid marker provides a minimally invasive (fine needles) and highly applicable alternative to current solid gold markers for multimodal image-guided prostate radiotherapy treatments.

show abstract

Section: Introductionmentioning

confidence: 99%